Ignite Creation Date:
2024-05-05 @ 11:20 AM
Last Modification Date:
2024-10-26 @ 9:02 AM
Study NCT ID:
NCT00002004
Status:
COMPLETED
Last Update Posted:
2005-06-24
First Post:
1999-11-02
Brief Title:
A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 rCD4 in Patients With AIDS and AIDS-Related Complex
Sponsor:
Genentech Inc
Organization:
NIH AIDS Clinical Trials Information Service
Study Overview
Official Title:
A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 rCD4 in Patients With AIDS and AIDS-Related Complex
Status:
COMPLETED
Status Verified Date:
1990-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To determine the safety profile and maximum tolerated dose MTD of recombinant soluble human CD4 rCD4 therapy in patients with AIDS or AIDS related complex ARC To assess pharmacokinetic properties of rCD4 in humans To obtain a preliminary indication of the antiviral effects of rCD4 in patients with AIDS and AIDS related complex ARC
Detailed Description:
None
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?:
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| Serial Number 002 | None | None | None |
| CO030g | None | None | None |